VIR insider buying and SEC filings, explained
Vir Biotechnology, Inc. · CIK 1706431
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$8.3M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jun 1, 2026 | Planned (10b5-1) | Janet Napolitano (Director) sold 3,200 shares at $9.45 ($30K), marked as a 10b5-1 plan trade. Holdings down 13% to 21,216 shares. | SEC filing Filed Jun 2, 2026 |
| Jun 1, 2026 | Planned (10b5-1) | Brent Sabatini (SVP, Chief Accounting Officer) sold 379 shares at $9.45 ($4K), marked as a 10b5-1 plan trade. Holdings down 1% to 61,902 shares. | SEC filing Filed Jun 2, 2026 |
| May 1, 2026 | Planned (10b5-1) | Vicki L. Sato (Director) sold 22,000 shares at about $10.05 ($221K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,078,391 shares. | SEC filing Filed May 4, 2026 |
| Apr 6, 2026 | Planned (10b5-1) | Backer Marianne De (CEO and Director) sold 72,559 shares at $9.16 ($665K), marked as a 10b5-1 plan trade. Holdings down 7% to 948,145 shares. | SEC filing Filed Apr 7, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | Vicki L. Sato (Director) sold 22,000 shares at about $9.07 ($200K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,100,391 shares. | SEC filing Filed Apr 2, 2026 |
| Mar 23, 2026 | Planned (10b5-1) | Brent Sabatini (SVP, Chief Accounting Officer) sold 7,711 shares at $9.12 ($70K), marked as a 10b5-1 plan trade. Holdings down 11% to 61,902 shares. | SEC filing Filed Mar 24, 2026 |
| Mar 2, 2026 | Planned (10b5-1) | Vicki L. Sato (Director) sold 22,000 shares at about $9.50 ($209K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,122,391 shares. | SEC filing Filed Mar 3, 2026 |
| Feb 24, 2026 | Planned (10b5-1) | Vicki L. Sato (Director) sold 42,377 shares at about $9.75 ($413K), marked as a 10b5-1 plan trade. Holdings down 4% to 1,144,391 shares. | SEC filing Filed Feb 26, 2026 |
| Feb 24, 2026 | Planned (10b5-1) | Brent Sabatini (SVP, Chief Accounting Officer) sold 1,430 shares at $9.53 ($14K), marked as a 10b5-1 plan trade. Holdings down 2% to 69,613 shares. | SEC filing Filed Feb 26, 2026 |
| Feb 24, 2026 | Planned (10b5-1) | Jason O'Byrne (CFO) sold 1,634 shares at $9.53 ($16K), marked as a 10b5-1 plan trade. Holdings down 1% to 162,615 shares. | SEC filing Filed Feb 26, 2026 |
| Feb 24–25, 2026 | Planned (10b5-1) | Mark Eisner (EVP and Chief Medical Officer) sold 3,505 shares between Feb 24 and Feb 25 at about $9.69 ($34K), marked as a 10b5-1 plan trade. Holdings down 2% to 154,024 shares. | SEC filing Filed Feb 26, 2026 |
| Feb 24–25, 2026 | Planned (10b5-1) | Verneuil Vanina de (EVP, General Counsel, Corp Sec) sold 16,817 shares between Feb 24 and Feb 25 at about $9.77 ($164K), marked as a 10b5-1 plan trade. Holdings down 13% to 112,982 shares. | SEC filing Filed Feb 26, 2026 |
| Feb 24, 2026 | Planned (10b5-1) | Backer Marianne De (CEO and Director) sold 14,762 shares at $9.53 ($141K), marked as a 10b5-1 plan trade. Holdings down 1% to 1,020,704 shares. | SEC filing Filed Feb 26, 2026 |
| Feb 23, 2026 | Planned (10b5-1) | Brent Sabatini (SVP, Chief Accounting Officer) sold 1,829 shares at $7.45 ($14K), marked as a 10b5-1 plan trade. Holdings down 3% to 71,043 shares. | SEC filing Filed Feb 24, 2026 |
| Feb 23, 2026 | Planned (10b5-1) | Jason O'Byrne (CFO) sold 2,089 shares at $7.45 ($16K), marked as a 10b5-1 plan trade. Holdings down 1% to 164,249 shares. | SEC filing Filed Feb 24, 2026 |
| Feb 23, 2026 | Planned (10b5-1) | Mark Eisner (EVP and Chief Medical Officer) sold 2,089 shares at $7.45 ($16K), marked as a 10b5-1 plan trade. Holdings down 1% to 157,529 shares. | SEC filing Filed Feb 24, 2026 |
| Feb 23, 2026 | Planned (10b5-1) | Verneuil Vanina de (EVP, General Counsel, Corp Sec) sold 4,445 shares at $7.45 ($33K), marked as a 10b5-1 plan trade. Holdings down 3% to 129,799 shares. | SEC filing Filed Feb 24, 2026 |
| Feb 23, 2026 | Planned (10b5-1) | Backer Marianne De (CEO and Director) sold 19,039 shares at $7.45 ($142K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,035,466 shares. | SEC filing Filed Feb 24, 2026 |
| Feb 13, 2026 | Planned (10b5-1) | Brent Sabatini (SVP, Chief Accounting Officer) sold 1,530 shares at $7.79 ($12K), marked as a 10b5-1 plan trade. Holdings down 3% to 47,872 shares. | SEC filing Filed Feb 18, 2026 |
| Feb 2, 2026 | Planned (10b5-1) | Vicki L. Sato (Director) sold 22,000 shares at about $7.71 ($170K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,144,391 shares. | SEC filing Filed Feb 3, 2026 |
| Jan 2, 2026 | Planned (10b5-1) | Vicki L. Sato (Director) sold 22,000 shares at about $5.93 ($130K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,166,391 shares. | SEC filing Filed Jan 5, 2026 |
| Dec 1, 2025 | Planned (10b5-1) | SB INVESTMENT ADVISERS (UK) LTD (10% owner) sold 191,854 shares indirectly at about $5.98 ($1.1M), marked as a 10b5-1 plan trade. Indirect holdings down 1% to 13,728,924 shares. Filed jointly with 2 other reporting owners. | SEC filing Filed Dec 3, 2025 |
| Dec 1, 2025 | Planned (10b5-1) | Vicki L. Sato (Director) sold 22,000 shares at about $6.00 ($132K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,188,391 shares. | SEC filing Filed Dec 2, 2025 |
| Nov 26–28, 2025 | Planned (10b5-1) | SB INVESTMENT ADVISERS (UK) LTD (10% owner) sold 189,431 shares indirectly between Nov 26, 2025 and Nov 28, 2025 at about $6.41 ($1.2M), marked as a 10b5-1 plan trade. Indirect holdings down 1% to 13,920,778 shares. Filed jointly with 2 other reporting owners. | SEC filing Filed Dec 1, 2025 |
| Nov 24–25, 2025 | Planned (10b5-1) | SB INVESTMENT ADVISERS (UK) LTD (10% owner) sold 463,774 shares indirectly between Nov 24, 2025 and Nov 25, 2025 at about $6.27 ($2.9M), marked as a 10b5-1 plan trade. Indirect holdings down 3% to 14,110,209 shares. Filed jointly with 2 other reporting owners. | SEC filing Filed Nov 26, 2025 |
| Nov 17, 2025 | Planned (10b5-1) | Jason O'Byrne (CFO) sold 6,799 shares at $5.56 ($38K), marked as a 10b5-1 plan trade. Holdings down 6% to 110,701 shares. | SEC filing Filed Nov 18, 2025 |
| Nov 5, 2025 | Planned (10b5-1) | Verneuil Vanina de (EVP, General Counsel, Corp Sec) sold 2,385 shares at $5.16 ($12K), marked as a 10b5-1 plan trade. Holdings down 3% to 78,210 shares. | SEC filing Filed Nov 7, 2025 |
| Nov 3, 2025 | Planned (10b5-1) | Verneuil Vanina de (EVP and General Counsel) sold 1,365 shares at $5.86 ($8K), marked as a 10b5-1 plan trade. Holdings down 2% to 80,595 shares. | SEC filing Filed Nov 4, 2025 |
| Nov 3, 2025 | Planned (10b5-1) | Vicki L. Sato (Director) sold 22,000 shares at about $5.64 ($124K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,210,391 shares. | SEC filing Filed Nov 4, 2025 |
17 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow VIR in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.